HEALTH● LOWJul 22 · Jul 22, 2026, 5:56 PM
GSK enters lung cancer market with FDA nod for Jideytro
Seeking Alpha Tech
GSK has received FDA approval for Jideytro, allowing the company to enter the lung cancer market. This approval introduces a new treatment option for lung cancer.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH32m agoWoman treated for Ebola in Nigeria evacuated to SwitzerlandThe Independent WorldHEALTH42m agoNigeria could declare Ebola outbreak over by Dec 7 – PateVanguard NigeriaHEALTH50m agoVice-President calls for expansion of medical research in UniversitiesThe HinduHEALTH1h agoEbola: Nigeria may declare outbreak over in December – MinisterPremium Times